Aspira Women's Health Inc. (AWH)
NASDAQ: AWH · Real-Time Price · USD
0.886
-0.014 (-1.56%)
Nov 4, 2024, 4:00 PM EST - Market closed
Aspira Women's Health Stock Forecast
Stock Price Forecast
The 2 analysts with 12-month price forecasts for AWH stock have an average target of 4.40, with a low estimate of 3.30 and a high estimate of 5.50. The average target predicts an increase of 396.61% from the current stock price of 0.89.
Analyst Consensus: Buy
* Price targets were last updated on Aug 14, 2024.
Analyst Ratings
The average analyst rating for AWH stock from 2 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | May '24 | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Alliance Global Partners | Alliance Global Partners | Strong Buy Maintains $7 → $5.5 | Strong Buy | Maintains | $7 → $5.5 | +520.77% | Aug 14, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $3.3 | Hold | Reiterates | $3.3 | +272.46% | Apr 10, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Maintains $4 → $3.3 | Hold | Maintains | $4 → $3.3 | +272.46% | Apr 1, 2024 |
| Cantor Fitzgerald | Cantor Fitzgerald | Hold Reiterates $4 | Hold | Reiterates | $4 | +351.47% | Sep 26, 2023 |
| Alliance Global Partners | Alliance Global Partners | Strong Buy Initiates $5.6 | Strong Buy | Initiates | $5.6 | +532.05% | Aug 22, 2023 |
Financial Forecast
Revenue This Year
10.58M
from 9.15M
Increased by 15.56%
Revenue Next Year
21.72M
from 10.58M
Increased by 105.32%
EPS This Year
-1.27
from -1.81
EPS Next Year
-0.66
from -1.27
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 11.4M | 29.9M | 42.3M | ||
| Avg | 10.6M | 21.7M | 36.8M | ||
| Low | 9.9M | 12.3M | 32.0M |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|
| High | 24.2% | 182.9% | 94.8% | ||
| Avg | 15.6% | 105.3% | 69.6% | ||
| Low | 8.0% | 15.9% | 47.4% |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -1.25 | -0.46 | -0.27 |
| Avg | -1.27 | -0.66 | -0.26 |
| Low | -1.30 | -0.85 | -0.25 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.